Diaint spol. s r.o.
- Address
- Sokolska Trida 1925/49, Moravska Ostrava, 702 00 Moravska Ostrava A Privoz, Czechia
Diaint spol. s r.o. - Lipid Metabolism Research Center
Diaint spol. s r.o. is a specialized clinical research center focused on metabolic disorders, with particular expertise in lipid metabolism abnormalities and cardiovascular risk factors. The center plays a vital role in advancing therapeutic interventions for patients with hypertriglyceridemia and related metabolic conditions.
- Severe hypertriglyceridemia (SHTG) clinical trials
- Novel RNA-based therapies for triglyceride reduction
- Cardiovascular risk assessment and management
The center is actively involved in evaluating plozasiran, an innovative therapeutic approach targeting elevated fasting serum triglyceride levels. Through participation in multiple Phase III studies including the SHASTA 3 and MUIR-3 trials, Diaint demonstrates its commitment to developing evidence-based treatments for patients across the spectrum of hypertriglyceridemia severity, from moderate elevations to severe cases requiring specialized intervention.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Arrowhead Pharmaceuticals Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diaint spol. s r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia | Arrowhead Pharmaceuticals Inc. | Phase III | Not Recruiting | Oct 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues | 2 | Unknown | 2024-10-31 | 2024-11-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.